IMPORTANT NOTICE: The date, time, and room assignment of YOUR presentation is SUBJECT TO CHANGE.
Proposal authors can use this tool to see where they have been placed in the program agenda for an Oral or Poster Session.
Scroll down to search by the Submitter or Author Name, by Date/Time, or by Keywords by expanding FILTERS.
Confirm your place in the schedule by following the instructions that were emailed to you. Each presentation must have a separate paid registration. Contact the ACCI office immedicately by email at admin@consumerinterests.org to report any conflict, all corrections to the details of the presentation (including author names and the order they are listed as this is how it will be in the final program), or if you have any questions. Please be sure to reference the session title(s), date(s), and time(s) when you contact us.
P117 Exploring Financial Toxicity of Type 2 Diabetes: A Phenomenological Study in India
Short Description
Clinical management in type 2 diabetes has received considerable attention, along with the concept of financial toxicity, encompassing the economic burden and psychological distress arising from the cost of care and diabetes management. However, the overall financial health of individuals impacted by financial toxicity remains underexplored in the context of diabetes. This pilot study explores financial toxicity experienced by diabetic patients in the northern parts of Hyderabad, India, to cover the costs of diabetes management by using a qualitative research method. Semi-structured interviews were used in a phenomenological research design, understanding the in-depth experiences and interpretations of four dyads, including patients, providers, and family members. Results showed varied responses as they relate to demographic characteristics, primarily social status and income level. Key findings from this study indicated that chronic diseases like diabetes are not the sole issue relating to financial stress; however, the financial toxicity becomes a lot more significant when diabetes is associated with other chronic diseases. Preliminary results emphasize the need for standardized assessment tools and causal mechanisms underlying clinical and economic outcomes. Policymakers must prioritize financial protection as a health system's goal, with equitable access to care, which is essential to mitigate financial toxicity in diabetes care.
Type of presentation
Accepted Poster Presentation